AstraZeneca has announced a $400 million investment in its global AZ Forest program me, raising its commitment to plant 200 million trees by 2030 and ensure their long-term survival....
The U.S. Food and Drug Administration later this week approved BioMarin Pharmaceutical's gene therapy for severe hemophilia A, the company said, giving patients with the inherited bleeding disorder an alternative to regular injections of missing....
To increase treatment accessibility in China, the Chinese pharmaceutical company CSPC Pharmaceutical Group said later this week that it has partnered with Pfizer in a strategic alliance to introduce a local brand of an oral COVID-19 therapy...
Manufacturing of Active Pharmaceutical Ingredients (APIs) is a critical step in the productionof pharmaceutical drugs.
Lupin Limited announced the achievement of a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor programme, which is being developed in collaboration with AbbVie Inc. to treat a variety...
Corona Remedies Pvt Ltd, based in the city, has announced the acquisition of the Myoril brand from global pharmaceutical giant Sanofi for Rs 234 crore. The Myoril brand will be acquired for the Indian market on June 28, 2023...
The US FDA has authorized Pfizer Inc and partner OPKO Health Inc's medication for growth hormone insufficiency in children, the firms announced this week. The drug's clearance, which comes after an initial rejection by the FDA in January...
Singapore-headquartered iNova Pharmaceuticals will buy a portfolio of consumer healthcare brands from Sackler-owned Mundipharma International for an enterprise value of $540 million, an iNova spokesperson said earlier this week....
According to Manav Teli, executive director of Lord's Mark Industries, government interventions such as streamlining regulatory processes, offering research and development grants, and facilitating partnerships between manufacturers...
Akums announced the approval of perampanel oral suspension by the Drug Controller General of India (DCGI). The perampanel oral suspension is a bioequivalent formulation to the US FDA-approved FYCOMPA (perampanel) oral suspension...
, CDSCO.jpg)
